PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsFlucytosine
Flucytosine
Ancobon, Flucytosine (flucytosine) is a small molecule pharmaceutical. Flucytosine was first approved as Ancobon on 1982-01-01. It is used to treat aids-related opportunistic infections, aspergillosis, candidiasis, chromoblastomycosis, and cryptococcal meningitis amongst others in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
nervous system diseasesD009422
skin and connective tissue diseasesD017437
immune system diseasesD007154
Trade Name
FDA
EMA
Ancobon, Flucytosine (discontinued: Flucytosine)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Flucytosine
Tradename
Company
Number
Date
Products
ANCOBONBausch Health CompaniesN-017001 RX1982-01-01
2 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
ancobonNew Drug Application2022-02-02
flucytosineANDA2025-07-28
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
D: Dermatologicals
D01: Antifungals for dermatological use
D01A: Antifungals for topical use
D01AE: Other antifungals for topical use in atc
D01AE21: Flucytosine
J: Antiinfectives for systemic use
J02: Antimycotics for systemic use
J02A: Antimycotics for systemic use
J02AX: Other antimycotics for systemic use in atc
J02AX01: Flucytosine
HCPCS
No data
Clinical
Clinical Trials
55 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
MeningitisD008581EFO_0000584G031641919
Cryptococcal meningitisD016919EFO_0007228B45.11641919
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
GlioblastomaD005909EFO_0000515107213
Hiv infectionsD015658EFO_0000764B20121610
AstrocytomaD001254EFO_00002716329
OligodendrogliomaD009837EFO_00006315116
LeukemiaD007938C954115
Myeloid leukemia acuteD015470C92.0314
Myeloid leukemiaD007951C92314
Myelodysplastic syndromesD009190D46112
Covid-19D000086382U07.122
HivD006678O98.7222
Show 4 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
GliomaD005910EFO_0000520626
NeoplasmsD009369C80545
Brain neoplasmsD001932EFO_0003833C71424
RecurrenceD012008313
GliosarcomaD018316313
Colorectal neoplasmsD015179323
Precursor cell lymphoblastic leukemia-lymphomaD054198C91.0212
SuicideD013405112
Gastrointestinal neoplasmsD005770C26.9212
Germ cell and embryonal neoplasmsD009373111
Show 4 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Pancreatic neoplasmsD010190EFO_0003860C2533
Urinary bladder neoplasmsD001749C6722
Non-small-cell lung carcinomaD00228922
Acute diseaseD00020811
AdenocarcinomaD00023011
PreleukemiaD01128911
SyndromeD01357711
Non-muscle invasive bladder neoplasmsD00009328411
Lung neoplasmsD008175C34.9011
Adenoviridae infectionsD000257EFO_1001259B34.011
Show 8 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Food-drug interactionsD01856511
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameFlucytosine
INNflucytosine
Description
Flucytosine is an organofluorine compound that is cytosine that is substituted at position 5 by a fluorine. A prodrug for the antifungal 5-fluorouracil, it is used for the treatment of systemic fungal infections. It has a role as a prodrug. It is an organofluorine compound, a pyrimidone, an aminopyrimidine, a nucleoside analogue and a pyrimidine antifungal drug. It is functionally related to a cytosine.
Classification
Small molecule
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Nc1nc(=O)[nH]cc1F
Identifiers
PDB
CAS-ID2022-85-7
RxCUI
ChEMBL IDCHEMBL1463
ChEBI ID5100
PubChem CID3366
DrugBankDB01099
UNII IDD83282DT06 (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 10,801 documents
View more details
Safety
Black-box Warning
Black-box warning for: Ancobon, Flucytosine
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
795 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use